SANUWAVE Reports Q4 Loss Despite Strong Revenue Growth

SANUWAVE Health reveals a significant loss despite revenue growth. The company's recent financial results show a loss of $12.7 million, contrasting with last year's profit. However, revenue increased by 47%, indicating potential for future growth.

Date: 21-03-2025

AI Rating: 5

Earnings Per Share (EPS): The report does not provide information on EPS.

Revenue Growth: SANUWAVE's revenue grew by 47%, rising from $7.0 million to $10.3 million year-over-year. This significant growth reflects increasing demand and potential business expansion, which could positively affect stock prices moving forward.

Net Income: The company reported a net loss of $12.7 million, a stark contrast to a profit of $18.2 million from the previous year. This negative shift in net income could raise concerns among investors, influencing stock prices negatively.

Profit Margins: The report does not provide details on profit margins.

Free Cash Flow (FCF): The report does not provide information on free cash flow.

Return on Equity (ROE): The report does not provide information on return on equity.

Looking ahead, SANUWAVE expects revenue growth of 45 to 55 percent for the first quarter of 2025 and anticipates total revenue between $48 to $50 million for the full year. This forward guidance is optimistic and may buffer investor sentiment against the current loss.

Stocks: SNWV